| Improved segmental isotope labeling of proteins and application to a larger protein T Otomo, K Teruya, K Uegaki, T Yamazaki, Y Kyogoku Journal of biomolecular NMR 14, 105-114, 1999 | 127 | 1999 |
| Orally administered amyloidophilic compound is effective in prolonging the incubation periods of animals cerebrally infected with prion diseases in a prion strain-dependent manner Y Kawasaki, K Kawagoe, C Chen, K Teruya, Y Sakasegawa, K Doh-Ura Journal of virology 81 (23), 12889-12898, 2007 | 124 | 2007 |
| Identification by NMR spectroscopy of residues at contact surfaces in large, slowly exchanging macromolecular complexes H Matsuo, KJ Walters, K Teruya, T Tanaka, GT Gassner, SJ Lippard, ... Journal of the American Chemical Society 121 (42), 9903-9904, 1999 | 124 | 1999 |
| Structure-based design, synthesis, and evaluation of peptide-mimetic SARS 3CL protease inhibitors K Akaji, H Konno, H Mitsui, K Teruya, Y Shimamoto, Y Hattori, T Ozaki, ... Journal of medicinal chemistry 54 (23), 7962-7973, 2011 | 104 | 2011 |
| Fused-ring structure of decahydroisoquinolin as a novel scaffold for SARS 3CL protease inhibitors Y Shimamoto, Y Hattori, K Kobayashi, K Teruya, A Sanjoh, A Nakagawa, ... Bioorganic & medicinal chemistry 23 (4), 876-890, 2015 | 103 | 2015 |
| The influence of PRNP polymorphisms on human prion disease susceptibility: an update A Kobayashi, K Teruya, Y Matsuura, T Shirai, Y Nakamura, M Yamada, ... Acta neuropathologica 130, 159-170, 2015 | 92 | 2015 |
| Human prion protein (PrP) 219K is converted to PrPSc but shows heterozygous inhibition in variant Creutzfeldt-Jakob disease infection M Hizume, A Kobayashi, K Teruya, H Ohashi, JW Ironside, S Mohri, ... Journal of biological chemistry 284 (6), 3603-3609, 2009 | 75 | 2009 |
| Synthesis of cyclic RGD derivatives via solid phase macrocyclization using the Heck reaction K Akaji, K Teruya, M Akaji, S Aimoto Tetrahedron 57 (12), 2293-2303, 2001 | 56 | 2001 |
| Antiprion activity of functionalized 9-aminoacridines related to quinacrine HTN Thi, CY Lee, K Teruya, WY Ong, K Doh-ura, ML Go Bioorganic & medicinal chemistry 16 (14), 6737-6746, 2008 | 44 | 2008 |
| Insights from therapeutic studies for PrP prion disease K Teruya, K Doh-Ura Cold Spring Harbor perspectives in medicine 7 (3), a024430, 2017 | 41 | 2017 |
| Synthesis and evaluation of phenylisoserine derivatives for the SARS-CoV 3CL protease inhibitor H Konno, T Onuma, I Nitanai, M Wakabayashi, S Yano, K Teruya, K Akaji Bioorganic & Medicinal Chemistry Letters 27 (12), 2746-2751, 2017 | 31 | 2017 |
| Solid-phase synthesis of HTLV-1 protease inhibitors containing hydroxyethylamine dipeptide isostere K Akaji, K Teruya, S Aimoto The Journal of Organic Chemistry 68 (12), 4755-4763, 2003 | 31 | 2003 |
| A single subcutaneous injection of cellulose ethers administered long before infection confers sustained protection against prion diseases in rodents K Teruya, A Oguma, K Nishizawa, M Kawata, Y Sakasegawa, ... PLoS Pathogens 12 (12), e1006045, 2016 | 27 | 2016 |
| Heterozygous inhibition in prion infection: the stone fence model A Kobayashi, M Hizume, K Teruya, S Mohri, T Kitamoto Prion 3 (1), 27-30, 2009 | 27 | 2009 |
| Polypeptide synthesis using an expressed peptide as a building block for condensation with a peptide thioester: application to the synthesis of phosphorylated p21Max protein (1 … T Kawakami, K Hasegawa, K Teruya, K Akaji, M Horiuchi, F Inagaki, ... Journal of Peptide Science: An Official Publication of the European Peptide …, 2001 | 27 | 2001 |
| Evaluating prion models based on comprehensive mutation data of mouse PrP T Shirai, M Saito, A Kobayashi, M Asano, M Hizume, S Ikeda, K Teruya, ... Structure 22 (4), 560-571, 2014 | 26 | 2014 |
| Binding and selectivity of the marine toxin neodysiherbaine A and its synthetic analogues to GluK1 and GluK2 kainate receptors M Unno, M Shinohara, K Takayama, H Tanaka, K Teruya, K Doh-Ura, ... Journal of molecular biology 413 (3), 667-683, 2011 | 24 | 2011 |
| Total synthesis of [L40I, C90A, C109A]-human T-cell leukemia virus type 1 protease K Teruya, T Kawakami, K Akaji, S Aimoto Tetrahedron letters 43 (8), 1487-1490, 2002 | 24 | 2002 |
| Amyloidophilic compounds for prion diseases K Teruya, K Kawagoe, T Kimura, C Chen, Y Sakasegawa, K Doh-ura Infectious Disorders-Drug Targets (Formerly Current Drug Targets-Infectious …, 2009 | 20 | 2009 |
| Semisynthesis of a protein with cholesterol at the C-terminal, targeted to the cell membrane of live cells K Teruya, K Nishizawa, K Doh-Ura The Protein Journal 29, 493-500, 2010 | 19 | 2010 |
